Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.
Choose from Drug Discovery Icon stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...
The table below is a review of notable updates that occurred in January 2025 for investigational products in development (not ... TROP2-directed DXd antibody drug conjugate Treatment of adults ...
The session will feature insights from Can-Fite's CEO Motti Farbstein and Executive Chairperson Dr. Pnina Fishman regarding the company's current development pipeline and milestones. Can-Fite aims ...
It added that it expects further growth to be boosted by its strong pipeline of new drugs, with 71 specialty medicines and vaccines now in clinical development. As a result, the company said it is ...
(Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline. The British drugmaker boosted its 2031 ...
It added that it expects further growth to be boosted by its strong pipeline of new drugs, with 71 specialty medicines and vaccines now in clinical development. As a result, the company said it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback